Enhanced measures of neoantigenicity capture unique tumor-immune interactions across primary melanoma subtypes
{{output}}
Background: As immune checkpoint inhibitor therapies move toward treatment of clinically high-risk localized primary melanoma, there is an increasing need for clear understanding of the tumor-immune interaction across primary mel... ...
